Premium
Sep 6, 2023
•
13 min read
A potential move to Schedule III means less taxes for cannabis companies. The rest we're not so sure about. That, and more.
Aug 30, 2023
4 min read
The U.S. Department of Health and Human Services (HHS) is recommending that cannabis be moved from Schedule I to Schedule III.
7 min read
It's a late August Hump Day. Take a breath, read some great stories.
Aug 10, 2023
15 min read
Plus, Tilray wants to be a beer company, earnings roundup, and more.
Aug 2, 2023
First up, we have MJ Reit CEO Chris Reece.
Jul 30, 2023
10 min read
"I have people who are willing to invest in me and bet on me . . . but I won’t take their money like I did last year because I can’t bet on the state," says Jeanette Miller, a Niagara County grower.
Jul 27, 2023
Plus, Tilray had a good day, Green Thumb Industries and Cresco Labs get into a spat, and much, much more.
Jul 25, 2023
6 min read
Today, Marc Hauser's Cannabis Musings is taking over Cultivated.
Jul 23, 2023
Fixing the mess in California is not simply a matter of fixing bad policy, writes Hirsh Jain, the founder of Ananda Strategy.
Jul 20, 2023
11 min read
Plus, Curaleaf wants a TSX listing, too.
Jul 14, 2023
8 min read
Plus, Cookies gets sued again, and Curaleaf wants to buy Cronos? Maybe?
Jul 12, 2023
It'll be a dogfight for the future of New York's legal cannabis market. Plus, a big new study into the public health impacts of legalization in Canada, and more.
Jun 28, 2023
9 min read
Plus, New York's regulatory woes, Glass House fires back, and more.
Jun 21, 2023
12 min read
Plus, Acreage Holdings gets walloped, a drug for cannabis addiction, and much more.
Jun 18, 2023
Introducing the Cultivated Sunday Read.
Jun 14, 2023
Plus, Pax launches gummies, Alabama's obsessed with peaches, and more.
Jun 8, 2023
The letter includes details of the severance package workers received.
Plus, notes on the short and long-term vision of this newsletter, and how to make capitalism work with, not against, journalism.
